Gala Therapeutics
  • DISEASE STATE
  • Patient Stories
  • TECHNOLOGY
  • CLINICAL STUDIES
  • Publications
  • NEWSROOM
  • ABOUT US
  • CONTACT US

Initial Study of the Minimally invasive RheOxTM Device…

Initial Study of the Minimally invasive RheOx™ Device…

#ats2019 #chronicbronchitis #rheox #galatherapeutics #gala

  • « Previous
  • Next »
  • DISEASE STATE
  • Patient Stories
  • TECHNOLOGY
  • CLINICAL STUDIES
  • Publications
  • NEWSROOM
  • ABOUT US
  • CONTACT US
  • Privacy Statement
  • Sitemap
  • Terms and Conditions

Copyright © 2022 Gala Therapeutics Inc. | All rights reserved.

RheOxTM is approved for sale in markets regulated by the CE mark only.

RheOx is an investigational device and limited by Federal (or United States) law to investigational use in the US.